Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. April 2022 07:00 ET | Quelle: MeMed

MeMed to host integrated symposium, oral presentation and poster spotlighting MeMed BV at the 32nd European Congress of Clinical Microbiology and Infectious Diseases Conference

MeMed to host integrated symposium, oral presentation and poster spotlighting MeMed BV at the 32nd European Congress of Clinical Microbiology and Infectious Diseases Conference Haifa, Israel;...
20. September 2021 02:00 ET | Quelle: MeMed

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test...
20. September 2021 02:00 ET | Quelle: MeMed

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test...
05. August 2021 07:00 ET | Quelle: MeMed

MeMed Named a Finalist for AACC’s Disruptive Technology Award for MeMed COVID-19 Severity™ Test

MeMed Named a Finalist for AACC’s Disruptive Technology Award for MeMed COVID-19 Severity™ Test MeMed COVID-19 Severity reads the immune-system in real time to accurately determine whether...